London hospital is the first to use femtosecond laser

Article

The London Eye Hospital is the first in the UK to use femtosecond laser for cataract removal and clear lens extraction.

The London Eye Hospital is the first in the UK to use femtosecond laser for cataract removal and clear lens extraction.

This replaces the current technique of making an incision with a blade of approximately 3mm. The cataract is then broken up using high frequency ultrasound.

Femtosecond laser surgery creates a 3D model of the eye at a real-time micron level of accuracy. The surgeon guides the laser, which then dissolves the lens or cataract. Treatment can be tailored for each patient's specifications.

Complication risk and the risk of infection are reduced with the femtosecond laser, making it a safer alternative to cataract and lens extraction.

Consultant ophthalmic surgeon and medical director at the London eye Hospital, Bobby Qureshi, said: "With this new breakthrough in laser refractive surgery, we can now offer a safe and effective alternative for cataract removal in the UK. Our brand new femtosecond laser has been specially designed to bring an extraordinary level of accuracy and reproducibility to refractive cataract surgery, making this the single greatest breakthrough in cataract and lens extraction surgery in nearly 30 years. No matter how accurate manual procedures may have seemed in the past, they simply cannot compete with the accuracy and precision that is now possible with laser cataract removal, which means that this surgery is now safer than ever before.”

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.